###begin article-title 0
###xml 8 14 8 14 <italic xmlns:xlink="http://www.w3.org/1999/xlink">STAT4 </italic>
###xml 126 138 126 138 <italic xmlns:xlink="http://www.w3.org/1999/xlink">STAT1-STAT4 </italic>
Role of STAT4 polymorphisms in systemic lupus erythematosus in a Japanese population: a case-control association study of the STAT1-STAT4 region
###end article-title 0
###begin p 1
This is an open access article distributed under the terms of the Creative Commons Attribution License (), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 1
###begin title 2
Introduction
###end title 2
###begin p 3
###xml 26 32 26 32 <italic xmlns:xlink="http://www.w3.org/1999/xlink">STAT4 </italic>
###xml 152 158 152 158 <italic xmlns:xlink="http://www.w3.org/1999/xlink">STAT1 </italic>
###xml 183 189 183 189 <italic xmlns:xlink="http://www.w3.org/1999/xlink">STAT4 </italic>
###xml 350 356 350 356 <italic xmlns:xlink="http://www.w3.org/1999/xlink">STAT4 </italic>
###xml 495 500 495 500 <italic xmlns:xlink="http://www.w3.org/1999/xlink">STAT1</italic>
###xml 646 651 646 651 <italic xmlns:xlink="http://www.w3.org/1999/xlink">STAT1</italic>
###xml 652 658 652 658 <italic xmlns:xlink="http://www.w3.org/1999/xlink">STAT4 </italic>
###xml 265 273 <span type="species:ncbi:9606">patients</span>
Recent studies identified STAT4 (signal transducers and activators of transcription-4) as a susceptibility gene for systemic lupus erythematosus (SLE). STAT1 is encoded adjacently to STAT4 on 2q32.2-q32.3, upregulated in peripheral blood mononuclear cells from SLE patients, and functionally relevant to SLE. This study was conducted to test whether STAT4 is associated with SLE in a Japanese population also, to identify the risk haplotype, and to examine the potential genetic contribution of STAT1. To accomplish these aims, we carried out a comprehensive association analysis of 52 tag single nucleotide polymorphisms (SNPs) encompassing the STAT1-STAT4 region.
###end p 3
###begin title 4
Methods
###end title 4
###begin p 5
###xml 189 197 <span type="species:ncbi:9606">patients</span>
###xml 341 349 <span type="species:ncbi:9606">patients</span>
In the first screening, 52 tag SNPs were selected based on HapMap Phase II JPT (Japanese in Tokyo, Japan) data, and case-control association analysis was carried out on 105 Japanese female patients with SLE and 102 female controls. For associated SNPs, additional cases and controls were genotyped and association was analyzed using 308 SLE patients and 306 controls. Estimation of haplotype frequencies and an association study using the permutation test were performed with Haploview version 4.0 software. Population attributable risk percentage was estimated to compare the epidemiological significance of the risk genotype among populations.
###end p 5
###begin title 6
Results
###end title 6
###begin p 7
###xml 65 71 65 71 <italic xmlns:xlink="http://www.w3.org/1999/xlink">STAT4 </italic>
###xml 107 109 107 109 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 163 168 163 168 <italic xmlns:xlink="http://www.w3.org/1999/xlink">STAT1</italic>
###xml 354 356 354 356 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 366 368 366 368 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-6</sup>
###xml 447 449 447 449 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 459 461 459 461 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-6</sup>
###xml 233 241 <span type="species:ncbi:9606">patients</span>
###xml 320 328 <span type="species:ncbi:9606">patients</span>
In the first screening, rs7574865, rs11889341, and rs10168266 in STAT4 were most significantly associated (P < 0.01). Significant association was not observed for STAT1. Subsequent association studies of the three SNPs using 308 SLE patients and 306 controls confirmed a strong association of the rs7574865T allele (SLE patients: 46.3%, controls: 33.5%, P = 4.9 x 10-6, odds ratio 1.71) as well as TTT haplotype (rs10168266/rs11889341/rs7574865) (P = 1.5 x 10-6). The association was stronger in subgroups of SLE with nephritis and anti-double-stranded DNA antibodies. Population attributable risk percentage was estimated to be higher in the Japanese population (40.2%) than in Americans of European descent (19.5%).
###end p 7
###begin title 8
Conclusions
###end title 8
###begin p 9
###xml 9 15 9 15 <italic xmlns:xlink="http://www.w3.org/1999/xlink">STAT4 </italic>
###xml 112 118 112 118 <italic xmlns:xlink="http://www.w3.org/1999/xlink">STAT1 </italic>
###xml 189 195 189 195 <italic xmlns:xlink="http://www.w3.org/1999/xlink">STAT4 </italic>
The same STAT4 risk allele is associated with SLE in Caucasian and Japanese populations. Evidence for a role of STAT1 in genetic susceptibility to SLE was not detected. The contribution of STAT4 for the genetic background of SLE may be greater in the Japanese population than in Americans of European descent.
###end p 9
###begin title 10
Introduction
###end title 10
###begin p 11
###xml 229 230 229 230 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 345 349 345 349 <italic xmlns:xlink="http://www.w3.org/1999/xlink">IRF5</italic>
###xml 428 429 428 429 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 430 431 430 431 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 459 465 459 465 <italic xmlns:xlink="http://www.w3.org/1999/xlink">STAT4 </italic>
###xml 592 593 592 593 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 647 648 647 648 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 649 650 649 650 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 676 682 676 682 <italic xmlns:xlink="http://www.w3.org/1999/xlink">STAT4 </italic>
###xml 704 706 704 706 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 748 750 748 750 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 779 781 779 781 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 846 852 846 852 <italic xmlns:xlink="http://www.w3.org/1999/xlink">STAT4 </italic>
###xml 985 987 985 987 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 988 990 988 990 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 1138 1139 1138 1139 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 1140 1142 1140 1142 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 1143 1145 1143 1145 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 1146 1148 1146 1148 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 1155 1161 1155 1161 <italic xmlns:xlink="http://www.w3.org/1999/xlink">STAT4 </italic>
###xml 1415 1417 1411 1413 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 1476 1478 1465 1467 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 1570 1572 1559 1561 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 1635 1637 1617 1619 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 1738 1744 1717 1723 <italic xmlns:xlink="http://www.w3.org/1999/xlink">STAT4 </italic>
###xml 1784 1786 1763 1765 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 1921 1923 1896 1898 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 2069 2071 2044 2046 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 2072 2074 2047 2049 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 2174 2186 2149 2161 <italic xmlns:xlink="http://www.w3.org/1999/xlink">STAT1-STAT4 </italic>
###xml 2281 2283 2256 2258 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 2379 2380 2354 2355 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 2511 2516 2486 2491 <italic xmlns:xlink="http://www.w3.org/1999/xlink">STAT1</italic>
###xml 2517 2523 2492 2498 <italic xmlns:xlink="http://www.w3.org/1999/xlink">STAT4 </italic>
###xml 2615 2621 2590 2596 <italic xmlns:xlink="http://www.w3.org/1999/xlink">STAT1 </italic>
###xml 2625 2630 2600 2605 <italic xmlns:xlink="http://www.w3.org/1999/xlink">STAT4</italic>
###xml 2015 2023 <span type="species:ncbi:9606">patients</span>
###xml 2048 2052 <span type="species:ncbi:10090">mice</span>
Systemic lupus erythematosus (SLE) is a complex disease characterized by autoantibody production and involvement of multiple organs, including kidneys. Both genetic and environmental factors contribute to the development of SLE [1]. Until now, several genes have been reported to be associated with SLE, of which interferon regulatory factor-5 (IRF5) has been identified as a susceptibility gene common to multiple populations [2-6]. Recently, association of STAT4 (signal transducers and activators of transcription-4) haplotype tagged by rs7574865T with SLE was demonstrated in Caucasians [7]. Subsequently, two genome-wide association studies [8,9], a study focused on the STAT4 region in Caucasians [10], and replication studies in Colombians [11] and a Japanese population [12] have confirmed the association. In addition, an association of STAT4 with SLE phenotypes such as anti-double-stranded DNA (anti-dsDNA) autoantibodies, renal disorder, and age at diagnosis was reported [10,13]. An association of rs7574865 with other autoimmune diseases such as rheumatoid arthritis and primary Sjogren syndrome has also been demonstrated [7,11,12,14]. The STAT4 gene encodes a transcription factor belonging to the STAT family expressed in lymphocytes, macrophages, and dendritic cells. STAT4 is essential for interleukin (IL)-12 signaling and induces interferon-gamma (IFNgamma) production and Th1 differentiation [15]. STAT4 is also activated by type I IFNs (IFNalpha/beta) [16]. Moreover, the requirement of STAT4 in IL-23-induced IL-17 production has been suggested [17]. Two isoforms of STAT4, STAT4alpha and STAT4beta, are known [18]. Expression of STAT4beta, lacking the transactivation domain, did not appear to be affected by the STAT4 single nucleotide polymorphisms (SNPs) [13]. STAT1, another member of the STAT family, is activated by type I IFNs and IFNgamma and plays an important role in immune responses [19]. STAT1 has been reported to be upregulated in peripheral blood mononuclear cells from SLE patients and in kidneys of lupus mice with nephritis [20,21], suggesting that STAT1 may play a role in the pathogenesis of SLE. A possible role of SNPs in the STAT1-STAT4 region other than the haplotype tagged by rs7574865T has recently been excluded in Caucasians [10]. However, in view of substantial differences in disease-associated alleles among populations [2], such analysis should be performed in each population. In this study, we carried out a comprehensive association analysis of the STAT1-STAT4 region with SLE in a Japanese population by scanning 52 tag SNPs of the region encompassing STAT1 and STAT4.
###end p 11
###begin title 12
Materials and methods
###end title 12
###begin title 13
###xml 0 8 <span type="species:ncbi:9606">Patients</span>
Patients and healthy controls
###end title 13
###begin p 14
###xml 574 576 570 572 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 698 700 694 696 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 0 8 <span type="species:ncbi:9606">Patients</span>
###xml 121 129 <span type="species:ncbi:9606">patients</span>
###xml 175 182 <span type="species:ncbi:9606">persons</span>
###xml 244 252 <span type="species:ncbi:9606">patients</span>
###xml 458 466 <span type="species:ncbi:9606">patients</span>
###xml 903 915 <span type="species:ncbi:9606">participants</span>
Patients and controls were recruited at Juntendo University, the University of Tsukuba, and the University of Tokyo. All patients and healthy controls were unrelated Japanese persons living in the central part of Japan. Three hundred eight SLE patients (18 males and 290 females, average age 41.4 +/- 13.5 years) and 306 healthy individuals (119 males and 187 females, average age 32.6 +/- 9.8 years) were studied. Diagnosis of SLE and classification of the patients into clinical subsets were carried out according to the American College of Rheumatology criteria for SLE [22]. There was no overlap in cases or controls between this study and the recently reported study in a Japanese population [12]. These studies were reviewed and approved by the research ethics committees of the University of Tsukuba, the University of Tokyo, and Juntendo University. Informed consent was obtained from all study participants.
###end p 14
###begin title 15
Association study
###end title 15
###begin p 16
###xml 26 31 26 31 <italic xmlns:xlink="http://www.w3.org/1999/xlink">STAT1</italic>
###xml 32 38 32 38 <italic xmlns:xlink="http://www.w3.org/1999/xlink">STAT4 </italic>
###xml 67 68 67 68 <italic xmlns:xlink="http://www.w3.org/1999/xlink">r</italic>
###xml 68 70 68 70 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2 </sup>
###xml 487 489 487 489 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 307 315 <span type="species:ncbi:9606">patients</span>
###xml 654 662 <span type="species:ncbi:9606">patients</span>
Fifty-two tag SNPs in the STAT1-STAT4 region were selected with an r2 threshold of 0.9 based on the HapMap Phase II JPT (Japanese in Tokyo, Japan) data. These tag SNPs captured 127 SNPs with a minor allele frequency of greater than or equal to 0.05. First screening was performed in 105 Japanese female SLE patients and 102 female healthy controls using the GoldenGate SNP genotyping assay (Illumina, Inc., San Diego, CA, USA). For the three SNPs that exhibited significant association (P < 0.01), additional samples were genotyped using the TaqMan SNP Genotyping Assay (Applied Biosystems, Foster City, CA, USA), and association was examined in 308 SLE patients and 306 healthy individuals.
###end p 16
###begin title 17
Statistical analysis
###end title 17
###begin p 18
###xml 172 174 172 174 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
Association of each SNP was analyzed by chi-square test. Because of the replicative nature of this study, correction for multiple testing was not performed, and unadjusted P values are shown. Haplotype frequency estimation and association analysis using the permutation test were performed with Haploview version 4.0 software (Broad Institute of MIT and Harvard, Cambridge, MA, USA). In the haplotype analysis, the genotype data for rs10168266, rs11889341, and rs7574865 were used and these SNPs were assumed to compose a single haplotype block. In the permutation test, only frequencies of haplotypes in this block were compared (that is, the 'Haplotypes in Blocks Only' option was used). Ten million permutations were performed. To test the significance of each SNP conditional on the genotypes of other SNPs, logistic regression analysis was performed under the additive model for the minor allele. Assuming a polymorphic site with two alleles A and a, genotypes were encoded as 0 = aa, 1 = Aa, and 2 = AA. Population attributable risk percentage (PAR%) for the risk genotype (rs7574865T/T and T/G) was estimated by the formula
###end p 18
###begin p 19

###end p 19
###begin p 20
###xml 120 122 120 122 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
where Pe represents the risk genotype frequency in the population and RR represents relative risk of the risk genotype [23]. Given the low prevalence of SLE, Pe can be estimated based on the genotype frequencies in healthy controls and RR can be approximated by odds ratio (OR) for the risk genotypes.
###end p 20
###begin title 21
Results and Discussion
###end title 21
###begin p 22
###xml 4 10 4 10 <italic xmlns:xlink="http://www.w3.org/1999/xlink">STAT4 </italic>
###xml 56 62 56 62 <italic xmlns:xlink="http://www.w3.org/1999/xlink">STAT1 </italic>
###xml 96 102 96 102 <italic xmlns:xlink="http://www.w3.org/1999/xlink">STAT1 </italic>
###xml 106 112 106 112 <italic xmlns:xlink="http://www.w3.org/1999/xlink">STAT4 </italic>
###xml 195 200 195 200 <italic xmlns:xlink="http://www.w3.org/1999/xlink">STAT1</italic>
###xml 201 207 201 207 <italic xmlns:xlink="http://www.w3.org/1999/xlink">STAT4 </italic>
###xml 232 233 232 233 <italic xmlns:xlink="http://www.w3.org/1999/xlink">r</italic>
###xml 233 235 233 235 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2 </sup>
###xml 530 535 530 535 <italic xmlns:xlink="http://www.w3.org/1999/xlink">STAT1</italic>
###xml 536 542 536 542 <italic xmlns:xlink="http://www.w3.org/1999/xlink">STAT4 </italic>
###xml 569 570 569 570 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 581 582 581 582 <italic xmlns:xlink="http://www.w3.org/1999/xlink">r</italic>
###xml 582 584 582 584 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2 </sup>
###xml 333 341 <span type="species:ncbi:9606">patients</span>
###xml 424 432 <span type="species:ncbi:9606">patients</span>
The STAT4 gene is located on 2q32.2-q32.3 adjacently to STAT1 gene, and the region encompassing STAT1 and STAT4 spans approximately 180 kilobase pairs. In the first screening, 52 tag SNPs in the STAT1-STAT4 region, selected with an r2 threshold of 0.9 based on the HapMap Phase II JPT data, were genotyped in 105 Japanese female SLE patients and 102 female healthy controls, and allele frequencies were compared between SLE patients and controls. A linkage disequilibrium (LD) plot and the results of the association study in the STAT1-STAT4 region are shown in Figure 1. Pairwise r2 values between 52 tag SNPs were calculated using genotyping data from 102 healthy individuals.
###end p 22
###begin p 23
###xml 35 47 35 47 <italic xmlns:xlink="http://www.w3.org/1999/xlink">STAT1-STAT4 </italic>
###xml 169 171 169 171 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 297 299 297 299 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 348 349 348 349 <italic xmlns:xlink="http://www.w3.org/1999/xlink">r</italic>
###xml 349 351 349 351 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2 </sup>
###xml 507 513 507 513 <italic xmlns:xlink="http://www.w3.org/1999/xlink">STAT1 </italic>
###xml 517 523 517 523 <italic xmlns:xlink="http://www.w3.org/1999/xlink">STAT4 </italic>
Linkage disequilibrium plot of the STAT1-STAT4 region in a Japanese population and first screening of 52 tag single nucleotide polymorphisms (SNPs). In the upper panel, P values for differences in allele frequencies were calculated by chi-square test using two-by-two contingency tables. The -log P value for each SNP is shown. In the lower panel, r2 values calculated using Haploview version 4.0 software based on data from 102 healthy individuals are shown. The location and direction of transcription of STAT1 and STAT4 are indicated by arrows. SNPs rs10168266, rs11889341, and rs7574865 belong to the same haplotype block.
###end p 23
###begin p 24
###xml 135 137 135 137 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 283 284 283 284 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 296 297 296 297 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 342 348 342 348 <italic xmlns:xlink="http://www.w3.org/1999/xlink">STAT4 </italic>
###xml 445 451 445 451 <italic xmlns:xlink="http://www.w3.org/1999/xlink">STAT1 </italic>
###xml 459 461 459 461 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
Among the tag SNPs, rs10168266C>T, rs11889341C>T, and rs7574865G>T were most significantly associated with SLE in the first screening (P < 0.01). Allele frequencies of rs10168266T, rs11889341T, and rs7574865T were significantly increased in SLE compared with healthy controls (Table 1 and Figure 1). These SNPs were located in the introns of STAT4 and in LD with each other. In contrast, significant association was not detected for SNPs in the STAT1 region (P > 0.05).
###end p 24
###begin p 25
###xml 29 31 29 31 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 88 93 88 93 <italic xmlns:xlink="http://www.w3.org/1999/xlink">STAT1</italic>
###xml 94 100 94 100 <italic xmlns:xlink="http://www.w3.org/1999/xlink">STAT4 </italic>
Minor allele frequencies and P values for 52 tag single nucleotide polymorphisms in the STAT1-STAT4 region in the first screening
###end p 25
###begin p 26
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink">a</sup>
aChromosomal positions are shown according to the National Center for Biotechnology Information (Bethesda, MD, USA) reference assembly. SLE, systemic lupus erythematosus; SNP, single nucleotide polymorphism; STAT, signal transducers and activators of transcription.
###end p 26
###begin p 27
###xml 256 257 256 257 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T2">2</xref>
###xml 352 354 352 354 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 527 529 527 529 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 539 541 539 541 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-6</sup>
###xml 71 79 <span type="species:ncbi:9606">patients</span>
###xml 206 214 <span type="species:ncbi:9606">patients</span>
###xml 479 487 <span type="species:ncbi:9606">patients</span>
To confirm the association detected in the first screening, additional patients and controls were genotyped for the three SNPs using the TaqMan SNP Genotyping Assay, and association was examined in 308 SLE patients and 306 healthy controls in total (Table 2). Significant deviation from Hardy-Weinberg equilibrium was not detected in healthy controls (P > 0.05). The rs7574865T allele, previously shown to be associated with SLE in Caucasians, was significantly increased in SLE patients (46.3%) compared with controls (33.5%, P = 4.9 x 10-6, OR 1.71). The association was compatible with the dominant model, under which the OR was 2.19 (T/T + G/T versus G/G).
###end p 27
###begin p 28
###xml 15 21 15 21 <italic xmlns:xlink="http://www.w3.org/1999/xlink">STAT4 </italic>
Association of STAT4 single nucleotide polymorphisms rs10168266, rs11889341, and rs7574865 with systemic lupus erythematosus
###end p 28
###begin p 29
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink">a</sup>
###xml 1 3 1 3 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 122 123 122 123 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b</sup>
###xml 123 125 123 125 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
aP values, odds ratios, and 95% confidence intervals (CIs) were calculated under the dominant model for the minor allele. bP values were calculated by permutation test using Haploview version 4.0 software. Ten million permutations were performed. NS, not significant; SLE, systemic lupus erythematosus; STAT, signal transducers and activators of transcription.
###end p 29
###begin p 30
###xml 62 63 62 63 <italic xmlns:xlink="http://www.w3.org/1999/xlink">r</italic>
###xml 63 64 63 64 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2</sup>
###xml 80 82 80 82 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D'</italic>
###xml 165 167 165 167 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 177 180 177 180 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-6 </sup>
###xml 184 186 184 186 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 196 198 196 198 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-6</sup>
###xml 369 371 369 371 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 381 383 381 383 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-6</sup>
###xml 519 521 519 521 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 531 533 531 533 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-5</sup>
###xml 693 694 693 694 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T3">3</xref>
The SNPs rs11889341 and rs10168266 were in LD with rs7574865 (r2: 0.57 to 0.78, D': 0.91 to 0.97) and were also significantly associated with SLE (allele frequency: P = 6.6 x 10-6 and P = 6.3 x 10-6, respectively). Haplotype analysis revealed that the haplotype carrying rs10168266T, rs11889341T, and rs7574865T was significantly increased (SLE: 36.8%, control: 24.3%, P = 1.5 x 10-6) whereas the haplotype carrying 10168266C, rs11889341C, and rs7574865G was significantly decreased in SLE (SLE: 52.7%, control: 65.0%, P = 1.0 x 10-5). Logistic regression analysis demonstrated that the association of each SNP lost statistical significance when adjusted for genotype of the other SNPs (Table 3). Thus, due to the strong LD, it was impossible to identify a single causative SNP among the three.
###end p 30
###begin p 31
###xml 111 116 111 116 <italic xmlns:xlink="http://www.w3.org/1999/xlink">STAT4</italic>
Logistic regression analysis of the systemic lupus erythematosus-associated single nucleotide polymorphisms in STAT4
###end p 31
###begin p 32
NA, not applicable; SNP, single nucleotide polymorphism; STAT, signal transducers and activators of transcription.
###end p 32
###begin p 33
###xml 23 29 23 29 <italic xmlns:xlink="http://www.w3.org/1999/xlink">STAT4 </italic>
###xml 178 184 178 184 <italic xmlns:xlink="http://www.w3.org/1999/xlink">STAT4 </italic>
###xml 284 286 284 286 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 295 296 295 296 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T4">4</xref>
###xml 374 376 374 376 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 386 388 386 388 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-5</sup>
###xml 433 435 433 435 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 1136 1138 1136 1138 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 349 357 <span type="species:ncbi:9606">patients</span>
###xml 493 501 <span type="species:ncbi:9606">patients</span>
###xml 699 707 <span type="species:ncbi:9606">patients</span>
###xml 811 819 <span type="species:ncbi:9606">patients</span>
###xml 906 914 <span type="species:ncbi:9606">patients</span>
We next tested whether STAT4 rs7574865 was associated with phenotypes of SLE such as presence of nephritis, anti-dsDNA antibodies, and early age of onset (less than 20 years) as STAT4 genotype has been shown to be more strongly associated with subgroups of SLE with these phenotypes [10] (Table 4). Association of rs7574865 was observed both in SLE patients with nephritis (P = 1.0 x 10-5, OR = 1.85) and in those without nephritis (P = 0.0031, OR = 1.55). The association was stronger in SLE patients with nephritis, although the difference between SLE with and without nephritis (case-only analysis) did not reach statistical significance. Similarly, rs7574865T was significantly increased in SLE patients with anti-dsDNA antibodies compared with healthy controls, whereas association was not detected in SLE patients without anti-dsDNA antibodies. The frequency of rs7574865T was slightly higher in the patients with an age of onset of less than 20 years as compared with greater than or equal to 20 years, although the difference was not statistically significant. These tendencies are consistent with those reported in Caucasians [10]. These interpretations were not affected when the significance level was corrected for the number of comparisons (three phenotypes).
###end p 33
###begin p 34
###xml 15 21 15 21 <italic xmlns:xlink="http://www.w3.org/1999/xlink">STAT4 </italic>
Association of STAT4 rs7574865 with characteristics of systemic lupus erythematosus such as nephritis, age of onset, and anti-double-stranded-DNA antibodies
###end p 34
###begin p 35
###xml 35 43 <span type="species:ncbi:9606">patients</span>
Systemic lupus erythematosus (SLE) patients were stratified into subgroups according to the presence or absence of nephritis, anti-double-stranded DNA (anti-dsDNA) antibodies, and age of onset (<20 or >/= 20 years). Allele frequencies were compared between each SLE subgroup and healthy controls as well as between SLE subgroups (case-only analysis, nephritis present versus absent, anti-dsDNA antibodies present versus absent, and age of onset <20 versus >/= 20 years). CI, confidence interval; NS, not significant; STAT, signal transducers and activators of transcription.
###end p 35
###begin p 36
###xml 48 54 48 54 <italic xmlns:xlink="http://www.w3.org/1999/xlink">STAT4 </italic>
###xml 238 239 238 239 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 240 242 240 242 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 243 245 243 245 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 254 255 254 255 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T5">5</xref>
###xml 412 413 412 413 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 627 629 627 629 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 650 652 650 652 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 861 867 861 867 <italic xmlns:xlink="http://www.w3.org/1999/xlink">STAT4 </italic>
###xml 162 169 <span type="species:ncbi:9606">persons</span>
To evaluate the epidemiological significance of STAT4 polymorphism in the genetic background of SLE in the Japanese population, we estimated the PAR% in Japanese persons and Caucasians using our present data and previously reported data [8,11,12] (Table 5). Because the frequency and OR of the risk genotype of rs7574865 were greater in the Japanese population than those of North Americans of European descent [8], PAR% in the Japanese population (40.2%) was much higher than that of the latter (19.5%). A similarly high PAR% was observed in two of the three Japanese case-control series reported by Kobayashi and colleagues [12] and in Colombians [11]. Because PAR% may be affected by the difference in the method of ascertainment of each study, this comparison may not be completely valid. Nevertheless, these observations suggested that the contribution of STAT4 for SLE is greater in the Japanese population as compared with the Americans of European descent.
###end p 36
###begin p 37
###xml 43 49 43 49 <italic xmlns:xlink="http://www.w3.org/1999/xlink">STAT4 </italic>
Population attributable risk percentage of STAT4 rs7574865 under the dominant model
###end p 37
###begin p 38
###xml 186 191 <span type="species:ncbi:9606">Women</span>
PAR%, population attributable risk percentage; RIKEN, The Institute of Physical and Chemical Research, Wako, Japan; STAT, signal transducers and activators of transcription; TWMU, Tokyo Women's Medical University, Tokyo, Japan.
###end p 38
###begin p 39
###xml 72 78 72 78 <italic xmlns:xlink="http://www.w3.org/1999/xlink">STAT4 </italic>
###xml 153 159 153 159 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Stat4 </italic>
###xml 187 193 187 193 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Stat4 </italic>
###xml 260 275 260 275 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sle1.Sle2.Sle3 </italic>
###xml 281 283 281 283 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 299 304 299 304 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Stat4</italic>
###xml 449 451 449 451 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 610 612 606 608 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 722 724 714 716 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 833 835 821 823 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 883 889 871 877 <italic xmlns:xlink="http://www.w3.org/1999/xlink">STAT4 </italic>
###xml 140 144 <span type="species:ncbi:10090">mice</span>
###xml 275 279 <span type="species:ncbi:10090">mice</span>
###xml 339 343 <span type="species:ncbi:10090">mice</span>
###xml 754 762 <span type="species:ncbi:9606">patients</span>
At this point, molecular mechanisms that account for the association of STAT4 intron SNPs with SLE remain unclear. Studies with lupus model mice lacking Stat4 showed conflicting results. Stat4 deficiency reduced nephritis and autoantibody production in B6.NZM.Sle1.Sle2.Sle3 mice [24]. In contrast, Stat4-deficient NZM (New Zealand mixed) mice developed accelerated nephritis and increased mortality in the absence of high levels of autoantibodies [25]. STAT4 has been shown to be involved in the induction of IFNgamma, differentiation of Th1 and Th17 cells, and signal transduction from type I IFN receptors [15]. Th1 cytokines, especially IFNgamma, have been shown to play a role in the pathogenesis of lupus nephritis [26]. Recently, T cells from SLE patients were shown to produce excessive amounts of IFNgamma upon stimulation [27]. These observations may implicate the role of STAT4 SNPs in IFNgamma production.
###end p 39
###begin p 40
###xml 53 54 53 54 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 182 184 182 184 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
###xml 185 187 185 187 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 209 213 209 213 <italic xmlns:xlink="http://www.w3.org/1999/xlink">IRF5</italic>
###xml 273 274 273 274 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 275 276 275 276 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 360 362 356 358 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 559 561 551 553 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
The role of type I IFNs in SLE has been established [1]. Elevated serum type I IFN levels and expression of IFN-inducible genes in peripheral mononuclear cells were reported in SLE [28,29]. The association of IRF5, which induces type I IFNs, with SLE has been established [2-6]. STAT4 is activated by type I IFN as well as IL-12 signals and produces IFNgamma [15]. Thus, STAT4 may also contribute to SLE as a component of the type I IFN signal pathway. Furthermore, STAT4 has been reported to transduce IL-12 signals to induce IFNgamma production in B cells [30].
###end p 40
###begin p 41
###xml 58 64 58 64 <italic xmlns:xlink="http://www.w3.org/1999/xlink">STAT4 </italic>
###xml 134 135 134 135 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T4">4</xref>
###xml 88 96 <span type="species:ncbi:9606">patients</span>
###xml 487 494 <span type="species:ncbi:9606">patient</span>
It is interesting to note that significant association of STAT4 was not observed in SLE patients without anti-dsDNA antibodies (Table 4). It would have been interesting to examine the effect of the genotype on the levels, rather than presence or absence, of anti-dsDNA antibody However, because the antibody levels fluctuate in association with disease activity and treatment, association with the genotype should be examined using the lifetime highest anti-dsDNA antibody level of each patient. Such data were not available for this study, and we hope that we can address this issue in the future.
###end p 41
###begin p 42
###xml 38 44 38 44 <italic xmlns:xlink="http://www.w3.org/1999/xlink">STAT4 </italic>
###xml 177 183 177 183 <italic xmlns:xlink="http://www.w3.org/1999/xlink">STAT4 </italic>
###xml 233 239 233 239 <italic xmlns:xlink="http://www.w3.org/1999/xlink">STAT4 </italic>
###xml 274 276 274 276 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
Most of these observations imply that STAT4 risk genotype may be associated with an elevated expression level and/or function of STAT4 protein. A recent study reported that the STAT4 risk allele was associated with overexpression of STAT4 in osteoblasts but not in B cells [13]. To address the significance of such findings, it will be necessary to examine the effect of this genotype on the expression levels and splicing isoforms in T and B cells.
###end p 42
###begin title 43
Conclusion
###end title 43
###begin p 44
###xml 50 55 50 55 <italic xmlns:xlink="http://www.w3.org/1999/xlink">STAT1</italic>
###xml 56 62 56 62 <italic xmlns:xlink="http://www.w3.org/1999/xlink">STAT4 </italic>
###xml 136 142 136 142 <italic xmlns:xlink="http://www.w3.org/1999/xlink">STAT4 </italic>
###xml 291 297 291 297 <italic xmlns:xlink="http://www.w3.org/1999/xlink">STAT1 </italic>
###xml 340 346 340 346 <italic xmlns:xlink="http://www.w3.org/1999/xlink">STAT4 </italic>
Through comprehensive association analysis of the STAT1-STAT4 region with SLE in the Japanese population, we demonstrated that the same STAT4 risk allele in Caucasians was strongly associated with susceptibility to SLE in the Japanese population. In contrast, evidence for an association of STAT1 SNPs was not observed. The contribution of STAT4 SNPs to the genetic background of SLE may be greater in the Japanese population than in Americans of European descent.
###end p 44
###begin title 45
Abbreviations
###end title 45
###begin p 46
anti-dsDNA: anti-double-stranded DNA; CI: confidence interval; IFN: interferon; IL: interleukin; IRF5: interferon regulatory factor-5; JPT: Japanese in Tokyo, Japan; LD: linkage disequilibrium; OR: odds ratio; PAR%: population attributable risk percentage; RR: relative risk; SLE: systemic lupus erythematosus; SNP: single nucleotide polymorphism; STAT: signal transducers and activators of transcription.
###end p 46
###begin title 47
Competing interests
###end title 47
###begin p 48
RRG, GH, and TWB are employees of and hold stocks or shares in Genentech, Inc. (South San Francisco, CA, USA). The other authors declare that they have no competing interests.
###end p 48
###begin title 49
Authors' contributions
###end title 49
###begin p 50
###xml 421 429 <span type="species:ncbi:9606">patients</span>
###xml 616 624 <span type="species:ncbi:9606">patients</span>
AK participated in the study design, carried out all genotyping and statistical analyses, and wrote the manuscript. II, KH, MK, and TA participated in the first screening using Illumina GoldenGate assay (with AK), including tag SNP selection, genotyping, and statistical analysis. JO carried out statistical analysis with AK and helped in the manuscript preparation. TH, DG, IM, SI, AT, YT, HH, and TS recruited Japanese patients with SLE and collected clinical information. RRG and GH provided Caucasian data. NT conceived of the study, together with TWB, and participated in its design and coordination, recruited patients and controls, and helped in the manuscript preparation. All authors read and approved the final manuscript.
###end p 50
###begin title 51
Acknowledgements
###end title 51
###begin p 52
This work was supported by KAKENHI (Grant-in-Aid for Scientific Research) (B) from the Japan Society for the Promotion of Science; KAKENHI on the Priority Area 'Applied Genomics' from the Ministry of Education, Culture, Sports, Science and Technology of Japan; and grants from the Ministry of Health, Labour and Welfare of Japan; the Japan Rheumatism Foundation; and the Naito Foundation.
###end p 52
###begin article-title 53
A compass that points to lupus: genetic studies on type I interferon pathway
###end article-title 53
###begin article-title 54
Association of IRF5 polymorphisms with systemic lupus erythematosus in a Japanese population: support for a crucial role of intron 1 polymorphisms
###end article-title 54
###begin article-title 55
Polymorphisms in the tyrosine kinase 2 and interferon regulatory factor 5 genes are associated with systemic lupus erythematosus
###end article-title 55
###begin article-title 56
###xml 54 58 54 58 <italic xmlns:xlink="http://www.w3.org/1999/xlink">IRF5</italic>
###xml 102 107 <span type="species:ncbi:9606">human</span>
Three functional variants of IFN regulatory factor 5 (IRF5) define risk and protective haplotypes for human lupus
###end article-title 56
###begin article-title 57
###xml 72 77 72 77 <italic xmlns:xlink="http://www.w3.org/1999/xlink">IRF5 </italic>
Opposed independent effects and epistasis in the complex association of IRF5 to SLE
###end article-title 57
###begin article-title 58
Interferon regulatory factor-5 is genetically associated with systemic lupus erythematosus in African Americans
###end article-title 58
###begin article-title 59
###xml 0 6 0 6 <italic xmlns:xlink="http://www.w3.org/1999/xlink">STAT4 </italic>
STAT4 and the risk of rheumatoid arthritis and systemic lupus erythematosus
###end article-title 59
###begin article-title 60
###xml 49 61 49 61 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C8orf13-BLK </italic>
###xml 65 76 65 76 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ITGAM-ITGAX</italic>
Association of systemic lupus erythematosus with C8orf13-BLK and ITGAM-ITGAX
###end article-title 60
###begin article-title 61
###xml 110 131 110 131 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ITGAM, PXK, KIAA1542 </italic>
###xml 32 37 <span type="species:ncbi:9606">women</span>
Genome-wide association scan in women with systemic lupus erythematosus identifies susceptibility variants in ITGAM, PXK, KIAA1542 and other loci
###end article-title 61
###begin article-title 62
###xml 19 25 19 25 <italic xmlns:xlink="http://www.w3.org/1999/xlink">STAT4 </italic>
Specificity of the STAT4 genetic association for severe disease manifestations of systemic lupus erythematosus
###end article-title 62
###begin article-title 63
###xml 0 6 0 6 <italic xmlns:xlink="http://www.w3.org/1999/xlink">STAT4 </italic>
###xml 14 23 14 23 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TRAF1/C5 </italic>
STAT4 but not TRAF1/C5 variants influence the risk of developing rheumatoid arthritis and systemic lupus erythematosus in Colombians
###end article-title 63
###begin article-title 64
###xml 15 21 15 21 <italic xmlns:xlink="http://www.w3.org/1999/xlink">STAT4 </italic>
Association of STAT4 with susceptibility to rheumatoid arthritis and systemic lupus erythematosus in the Japanese population
###end article-title 64
###begin article-title 65
###xml 9 15 9 15 <italic xmlns:xlink="http://www.w3.org/1999/xlink">STAT4 </italic>
###xml 156 161 156 161 <italic xmlns:xlink="http://www.w3.org/1999/xlink">IRF5 </italic>
A common STAT4 risk haplotype for systemic lupus erythematosus is over-expressed, correlates with anti-dsDNA production and shows additive effects with two IRF5 risk alleles
###end article-title 65
###begin article-title 66
###xml 16 22 16 22 <italic xmlns:xlink="http://www.w3.org/1999/xlink">STAT4 </italic>
Variant form of STAT4 is associated with primary Sjogren's syndrome
###end article-title 66
###begin article-title 67
###xml 63 68 63 68 <italic xmlns:xlink="http://www.w3.org/1999/xlink">STAT4</italic>
Signaling by IL-12 and IL-23 and the immunoregulatory roles of STAT4
###end article-title 67
###begin article-title 68
Critical role for STAT4 activation by type 1 interferons in the interferon-gamma response to viral infection
###end article-title 68
###begin article-title 69
###xml 0 6 0 6 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Stat3 </italic>
###xml 10 16 10 16 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Stat4 </italic>
Stat3 and Stat4 direct development of IL-17-secreting Th cells
###end article-title 69
###begin article-title 70
Distinct requirements for the naturally occurring splice forms Stat4alpha and Stat4beta in IL-12 responses
###end article-title 70
###begin article-title 71
STAT family of transcription factors in cytokine-mediated biological responses
###end article-title 71
###begin article-title 72
###xml 35 40 <span type="species:ncbi:9606">human</span>
The emerging role of interferon in human systemic lupus erythematosus
###end article-title 72
###begin article-title 73
###xml 73 77 <span type="species:ncbi:10090">mice</span>
Activation of the STAT1 signalling pathway in lupus nephritis in MRL/lpr mice
###end article-title 73
###begin article-title 74
Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus
###end article-title 74
###begin article-title 75
Examining complex genetic interactions
###end article-title 75
###begin article-title 76
###xml 77 82 <span type="species:ncbi:10090">mouse</span>
STAT4 deficiency reduces autoantibody production and glomerulonephritis in a mouse model of lupus
###end article-title 76
###begin article-title 77
###xml 108 112 <span type="species:ncbi:10090">mice</span>
Pivotal role of Stat4 and Stat6 in the pathogenesis of the lupus-like disease in the New Zealand mixed 2328 mice
###end article-title 77
###begin article-title 78
Th1/Th2 balance of peripheral T helper cells in systemic lupus erythematosus
###end article-title 78
###begin article-title 79
###xml 37 45 <span type="species:ncbi:9606">patients</span>
Excessive production of IFN-gamma in patients with systemic lupus erythematosus and its contribution to induction of B lymphocyte stimulator/B cell-activating factor/TNF ligand superfamily-13B
###end article-title 79
###begin article-title 80
Interferon-alpha: a new target for therapy in systemic lupus erythematosus?
###end article-title 80
###begin article-title 81
###xml 76 84 <span type="species:ncbi:9606">patients</span>
Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus
###end article-title 81
###begin article-title 82
###xml 3 8 <span type="species:ncbi:9606">human</span>
In human B cells, IL-12 triggers a cascade of molecular events similar to Th1 commitment
###end article-title 82

